A detailed history of Acadian Asset Management LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 42,367 shares of FHTX stock, worth $341,901. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,367
Previous 42,367 -0.0%
Holding current value
$341,901
Previous $283,000 14.13%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.82 - $7.94 $119,474 - $336,393
42,367 New
42,367 $283,000
Q1 2023

May 11, 2023

BUY
$4.66 - $8.99 $16,515 - $31,860
3,544 Added 15.05%
27,085 $165,000
Q4 2022

Feb 14, 2023

BUY
$5.44 - $9.46 $104,344 - $181,452
19,181 Added 439.93%
23,541 $149,000
Q3 2022

Nov 14, 2022

BUY
$7.52 - $18.01 $32,787 - $78,523
4,360 New
4,360 $37,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.